One of the central issues in the medical care of patients with diabetes is whether tight glycemic control will decrease Cardio-vascular Disease (CVD) morbidity and mortality. It is a leading cause of blindness, end stage renal disease and stroke. These obstacles are two to five times more regular among diabetic patients. Glycemic control remains a delicate balancing act. The Glucose Control and Vascular Complications in Veterans with type 2 diabetes Trial (VADT) compared the effects of intensive therapy versus standard glucose control on cardiovascular events. The diabetic patient is tasked with maintaining euglycemic blood glucose levels and intensive self-management with frequent self-monitoring of blood glucose (SMBG) is important in type 1 diabetes to achieve good metabolic control. Despite the increasing popularity of diabetes, enhanced understanding of the disease, and collections of new medications, glycemic control does not appear to be improving.
Research Article: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Review Article: Cardiovascular Diseases & Diagnosis
Review Article: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Case Report: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Research Article: Cardiovascular Diseases & Diagnosis
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Posters-Accepted Abstracts: Cancer Science & Therapy
Posters-Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report